ПОИСК ПО САЙТУ 
поиск по ресурсному центру Once the sensor reaches the stomach, it transmits a signal to a patch worn by the patient, and a digital record is sent to an app on the patient’s mobile device.
Researchers reported positive results from a study of “digital PrEP,” a novel formulation of the PrEP pill that has a tiny, embedded, ingestible sensor.
Innovative research on “digital PrEP”
Once the sensor reaches the stomach, it transmits a signal to a patch worn by the patient, and a digital record is sent to an app on the patient’s mobile device. With the patient’s permission, this data would be accessible to healthcare providers, allowing for near real-time remote confirmation and adherence support.
The single-arm, open-label study, presented by Sara H Browne of the University of California San Diego, enrolled 60 HIV-negative men who wished to take PrEP. Results showed that digital PrEP was pharmacokinetically equivalent to regular PrEP, and 92% of participants reported having a positive experience with the system.
